Status:
UNKNOWN
A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis
Lead Sponsor:
Peking University
Collaborating Sponsors:
RenJi Hospital
Ruijin Hospital
Conditions:
Gastric Cancer
Gastric Cancer Stage
Eligibility:
All Genders
18+ years
Brief Summary
With the introducing of neoadjuvant therapy, it becomes ever more important to evaluate the preoperative TNM (cTNM) stage accurately facilitating preoperative treatment as well as the adjuvant therapy...
Detailed Description
OBJECTIVES: I. Confirm the inclusion of pathological stage I (pI) among clinical stage III(T3-4aNx) (cIII) diagnosis patients less than 5% II. Figure out the suitable criterion of NAC and avoid overt...
Eligibility Criteria
Inclusion
- Histological prove of adenocarcinoma of the stomach by endoscopy
- Preoperative imaging data by contrast-enhanced CT and clinical TNM stages were given
- No evidence of stage IV disease
- No previous gastrectomy or preoperative treatment.
Exclusion
- Discovery of distant metastasis (stage IV) during surgery
- Number of retrieved lymph node less than 15
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
968 Patients enrolled
Trial Details
Trial ID
NCT04440605
Start Date
July 1 2020
End Date
October 1 2022
Last Update
June 19 2020
Active Locations (38)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Cancer Hospital & Institute
Beijing, Beijing Municipality, China, 100142
2
301 Hospital
Beijing, Beijing Municipality, China
3
302 Military Hospital of China
Beijing, Beijing Municipality, China
4
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China